In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to explore recent examples of diagnostic innovations that are improving patient care. Dr. Pritt also welcomes Matthew Schultz, Ph.D., a clinical biochemical geneticist at Mayo Clinic, to discuss how a novel test is delivering answers for patients with a recently identified peripheral neuropathy.

• Transplant testing innovations (00:57): Discover how advances in clinical diagnostics are improving transplant outcomes at Mayo Clinic.
• Advances reshaping rheumatoid arthritis diagnostics (06:06): Learn how early-stage research and emerging tools are reshaping care for patients with rheumatoid arthritis.
• New test for peripheral neuropathy (08:18): A novel test created to support care for patients with a recently identified condition now supporting research to advance care.

Note: Information in this post was accurate at the time of its posting.

Resources

• Rewriting the future of rheumatoid arthritis: How early detection is transforming prevention
• Cultivating a comprehensive test menu for organ transplant patients
• Screening test for sorbitol dehydrogenase deficiency-related neuropathy (SORD)
• Innovative SORD test provides clarity for two young patients: Justin Fugelsang and Zach Pedowitz